Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.8 HKD | -4.61% | -10.77% | -83.80% |
Apr. 17 | Sirnaomics Receives US FDA Guidance on Trials for Squamous Cell Carcinoma Treatment | MT |
Mar. 27 | Sirnaomics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 | - | Sales 2024 * | 2M 15.66M | Capitalization | 64.28M 503M |
---|---|---|---|---|---|
Net income 2023 | -78M -611M | Net income 2024 * | -124M -971M | EV / Sales 2023 | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 32.1 x |
P/E ratio 2023 |
-4.45
x | P/E ratio 2024 * |
-0.53
x | Employees | 145 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 81.24% |
1 day | -4.61% | ||
1 week | -10.77% | ||
Current month | -31.20% | ||
1 month | -29.18% | ||
3 months | -81.17% | ||
6 months | -87.95% | ||
Current year | -83.80% |
Managers | Title | Age | Since |
---|---|---|---|
Patrick Lu
CEO | Chief Executive Officer | 68 | 20-10-14 |
Wing Kei Yip
DFI | Director of Finance/CFO | 39 | 18-09-30 |
David Evans
CTO | Chief Tech/Sci/R&D Officer | 61 | 21-07-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Feng Mao Hua
BRD | Director/Board Member | 56 | 21-11-30 |
Patrick Lu
CEO | Chief Executive Officer | 68 | 20-10-14 |
David Evans
CTO | Chief Tech/Sci/R&D Officer | 61 | 21-07-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.50% | 4 M€ | -27.92% | ||
0.00% | 34 M€ | +1.25% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 5.8 | -4.61% | 2,285,600 |
24-04-18 | 6.08 | -2.09% | 5,050,000 |
24-04-17 | 6.21 | +3.16% | 14,896,500 |
24-04-16 | 6.02 | -13.26% | 4,251,550 |
24-04-15 | 6.94 | +6.77% | 11,871,950 |
Delayed Quote Hong Kong S.E., April 19, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-83.80% | 67.4M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- 2257 Stock